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Aim To estimate prevalence and incidence of attention def-
icit hyperactivity disorder (ADHD) in children and adoles-
cents in Slovenia using different epidemiological models.
Methods Data from the National Institute of Public Health 
of the Republic of Slovenia for the period 1997-2012 were 
analyzed. The database includes the annual number of 
newly diagnosed outpatients with ADHD in Slovenia. The 
evaluation for ADHD diagnoses was done in accordance 
with the Tenth Revision of the International Classification 
of Diseases (ICD-10) outpatient data codes. In model 1, a 
linear increase was proposed to fit the data in the period 
from 1997 to 2003 in order to extrapolate the data before 
1997. In model 2 and 3, an exponential increase in the an-
nual incidence rate was proposed.
Results The incidence rate of ADHD diagnosis in 1997 was 
0.032% and in 2012 it increased to 0.082%. Mean preva-
lence rate was 750 (95% confidence interval: 660-840) per 
100 000 children and adolescents. It was estimated that the 
prevalence rate in 2020 would be 1% (95% confidence in-
terval: 0.875-1.125), which is 6.3-fold higher than in 1997.
Conclusions ADHD is a common mental health disorder 
among Slovenian children and adolescents, but it remained 
underdiagnosed compared with Western countries. Our 
results indicated a need for improved timely interventions 
in Slovenia, not only in child and adolescent psychiatry but 
also in primary settings and adult psychiatry, where ADHD 
should be more efficiently recognized.
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Attention deficit hyperactivity disorder (ADHD) is one of the 
most common psychiatric disorders in childhood and ado-
lescence, characterized by developmentally inappropriate 
inattention, hyperactivity, and/or impulsivity (1). It entails 
economic costs, causes family stress and academic and vo-
cational adversity, and has a negative effect on the patient’s 
self-esteem (2). Although it is seen as a problem that takes 
place predominantly in childhood and adolescence, clinical 
and epidemiological research has shown that in 30–50% of 
patients ADHD persists into adulthood (3,4).
Children exhibiting symptoms of inattention, hyperactiv-
ity, and impulsivity have been described previously (5). In 
1980, the third edition of Diagnostic and Statistical Manu-
al of Mental Disorders (DSM-III) introduced the term “ADD 
(Attention-Deficit Disorder) with or without hyperactivity.” 
DSM-III-R (1987) replaced this term by the term ADHD and 
DSM-IV presented the subtypes of ADHD (6-9).
ADHD affects 3% to 9% of children worldwide (10). In Eu-
ropean countries, it is identified as a hyperkinetic disorder 
according to the 10th Revision of the International Statisti-
cal Classification of Diseases and Related Health Problems 
(ICD-10) and in North America as ADHD (DSM-IV). DSM-IV 
criteria include a broader group of subjects than the ICD-
10 criteria (11,12).
While the popular press across Europe frequently com-
ments on increased rates of ADHD diagnosis, questioning 
whether ADHD is overdiagnosed and overtreated, reviews 
of clinical practice suggest that in Europe ADHD is under-
diagnosed and undertreated (13,14). ADHD is underdiag-
nosed especially in adults; which is why it is important to 
better understand the factors that contribute to accurate 
diagnosis (15). Diagnosis and management of ADHD in-
clude nonpharmacological treatment, including behav-
ioral therapy, and pharmacological treatment with stimu-
lants and nonstimulants (16). In many European countries 
including Slovenia, the incidence and prevalence of this 
disorder are not well researched. In Slovenia, there are 
also no national guidelines for ADHD treatment and diag-
nosis and no published data on the prevalence of ADHD 
(17,18). The primary aim of this study was to calculate the 
incidence and prevalence of ADHD diagnosis among chil-
dren and adolescents in Slovenia in 2012, based on na-
tional data from 1997 to 2012. For this purpose, several 
different epidemiological models were developed. The 
secondary aim was to predict the number of Slovenian 




The national epidemiological data were obtained from da-
tabase of the National Institute of Public Health of the Re-
public of Slovenia (NIPH) (19). The database includes infor-
mation on the annual number of new patients diagnosed 
with ADHD in Slovenia from 1997 onwards, and their so-
ciodemographic data. In Slovenia, the diagnosis of ADHD 
in children and adolescents can be made only by psychia-
trists with specialization in child and adolescent psychiatry. 
At the first visit to the family physician after the diagnosis, 
the patient gets a diagnosis record, which is included in 
the database. The required population data were obtained 
from the Statistical Office of the Republic of Slovenia (20).
This study included the data regarding the following di-
agnoses: hyperkinetic disorders (F90), disturbance of ac-
tivity and attention (F90.0), hyperkinetic conduct disorder 
(F90.1), other hyperkinetic disorders (F90.8), and unspeci-
fied hyperkinetic disorder (F90.9). The participants’ selec-
tion was limited to those younger than 19 years. Ethical 
approval was received from the National Medical Ethics 
Committee of the Republic of Slovenia.
Modeling the annual incidence rate of Adhd diagnosis
The estimate of annual incidence rate was calculated as 
the ratio of the number of newly diagnosed children and 
adolescents with ADHD and the total number of people 
younger than 19 years. As the data regarding the number 
of newly diagnosed patients with ADHD had been collect-
ed only from 1997 onward, the incidence rate of ADHD di-
agnosis was modeled in order to estimate the incidence 
rate before 1997. The annual incidence rate was increasing 
in the period from 1997 to 2003, reaching a plateau from 
2004 to 2012.
In model 1, in order to extrapolate the data before 1997, it 
was assumed that in the period from 1997 to 2003 there 
was a linear increase in incidence (for the purpose of the 
study, we assumed that the incidence rate before 1997 was 
zero). A linear regression model (Eq.1) was used to calculate 
the slope of the line (b), presenting the increase in annual 
incidence rate (I) per one year. The intercept (a) represents 
the estimated annual incidence rate in 1997 as the variable 
t (years) in Eq 1 was set to zero for the year 1997:
 Eq (1)
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In the model 2 and 3, an exponential increase was as-
sumed. An exponential regression model was used to es-
timate the rate constant (k) of incidence rate increase and 
the intercept A, which represents the estimated annual in-
cidence rate for 1997:
 Eq (2)
The exponential model approximates to zero incidence 
rate, thus two starting points were selected. For model 2, 
the starting point was set to 1987 as in this year ADD was 
replaced by ADHD in the DSM-III-R (8). For model 3, the 
starting point was set to 1980 as in this year ADD, with or 
without hyperactivity, was introduced to the DSM-III (7).
We also estimated the prevalence rate without the extrap-
olation of the annual incidence rate before 1997 (raw data 
approach). In this approach it was assumed that in Slove-
nia no ADHD diagnosis existed before 1997.
the estimation of prevalence rate of Adhd diagnosis
Estimate of prevalence rate (P) of ADHD diagnosis among 
children and adolescents was calculated on the basis of 
the estimate of annual incidence rate (I) and the propor-
tion of patients who reached the age of 19 each year (G), 
using a recursive formula:
 Eq (3)
where index n denotes the specific year (eg, 2012). It was 
assumed that the percentage of patients with ADHD who 
annually reached the age of 19 equaled to the ratio of the 
number of all 19-year-olds and the total number of all peo-
ple aged 19 or younger. The required population data for 
the period from 1997 to 2013 were obtained from the Sta-
tistical Office of the Republic of Slovenia (20). The initial 
condition of the recursive formula (Eq. 3) varied accord-
ing to the approach used for modeling the incidence rate 
(models 1-3 or raw data approach). The lower and upper 
limits of the 95% confidence interval of estimated preva-
lence rate were calculated on the basis of the Eq. 3 and 
separately using lower and upper limits of the 95% confi-
dence interval (95% CI) of annual incidence rate at the pla-
teau (from the period between 2004 and 2012).
Additionally, we predicted the prevalence rate for the year 
2020. For this purpose the percentage of patients who 
reached the age of 19 after 2013 was calculated as the 
mean value of the previous three years (ie, 2011-2013). The 
incidence rate was assumed to be constant for the years 
2013 to 2020, corresponding to the value of the incidence 
rate plateau reached in the period from 2004 to 2012. Ad-
ditionally, we estimated the number of people aged 19 
or younger for the year 2020 on the basis of a geometric 
growth model, where the geometric growth rate was con-
stant and equaled to the mean growth rate in the previous 
three years (2011-2013). Tables and graphs were made in 
Microsoft Excel® 2010 (Microsoft Corporation, Redmond, 
WA, USA).
ResuLts
Modeling the annual incidence rate of Adhd in 
slovenia
The annual incidence rates of ADHD diagnosis in Slove-
nia increased from 1997 to 2003 (2.4-fold) (Table 1). Mean 
value of ADHD annual incidence rate between 2004 and 
2012 was 77 (95% CI 67-87, n = 9). Epidemiological models 
were used for calculation of incidence rates (Figure 1). The 
calculated parameters of linear models were as follows: 
a = 27.67, b = 6.909, r2 = 0.875; exponential model: A = 30.36, 
k = 0.141, and r2 = 0.931.
the estimation of prevalence rate of Adhd in slovenia
The point estimates of the prevalence rate calculated on 
the basis of 4 different models were used for calculation 
of the annual incidence rate (Figure 2). The deviation of 
the point estimates of the prevalence rate obtained by 
different models was relatively small: 6.0% for 2012. The 
FIguRe 1. the annual slovenian incidence rate of attention 
deficit hyperactivity disorder (Adhd) per 100 000 children and 
adolescents (Ch&Ad). Raw data (diamonds), linear model (line 
with circles), exponential model 2 (line with triangles).
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mean prevalence of children and adolescents with ADHD 
in 2012 was 2950 (95% CI 2600-3300) or 750 (95% CI 660-
840) per 100 000 children and adolescents. The predicted 
prevalence rate for 2020 was 1000 (95% CI 875-1125) per 
100 000 children and adolescents or 1%, meaning that in 
2020, 4050 (95% CI 3550-4550) children and adolescents 
will be diagnosed with ADHD.
The prevalence rate of ADHD diagnosis in Slovenia in-
creased 4.8-fold from 1997 to 2012. In this period, the prev-
alence rate increased almost linearly.
The prevalence of ADHD diagnosis in 2020 was predict-
ed to be 6.3-fold higher than in 1997, 1.3-fold higher than 
in 2012, and 1.8-fold higher than in 2007. All values were 
calculated using the exponential model with the starting 
point at 1980, because the differences within this mod-
el were smallest, although the differences among all the 
models were very small.
dIsCussIon
In the observed period, the annual incidence rates of 
ADHD diagnosis in Slovenia increased logarithmically and 
the prevalence rates increased linearly. The annual inci-
dence increased 1.5-fold from 1997 to 2000 and 2.5-fold 
from 1997 to 2003. The prevalence of ADHD diagnosis in-
creased 3.5-fold from 2000 to 2012 and 2.5-fold from 2000 
to 2006. The increase in the incidence and prevalence in 
Slovenia is similar to that in Western countries (21) and 
could mainly be attributed to the implementation of new 
diagnostic criteria (ICD-10 and DSM-IV), which are more 
detailed than those used previously (ICD-9, DSM-III-R) 
(5,8,9). Second, the teachers and parents may be more sen-
sitive to ADHD symptoms, which increases the number of 
tAbLe 1. Annual incidence of attention deficit hyperactivity disorder (Adhd) obtained from national database and the slovenian 









Proportion of  
1-y olds (%)*
Incidence rate 
per 100 000 children 
and adolescents
1997 156 491,915 29,946 6.09 31.7
1998 166 479,240 30,505 6.37 34.6
1999 177 467,980 30,061 6.42 37.8
2000 214 456,145 29,730 6.52 46.9
2001 254 444,360 28,820 6.49 57.2
2002 230 433,884 27,472 6.33 53.0
2003 329 424,472 26,949 6.35 77.5
2004 354 415,850 26,661 6.41 85.1
2005 316 408,383 25,069 6.14 77.4
2006 303 403,028 25,880 6.42 75.2
2007 224 397,958 26,388 6.63 56.3
2008 334 394,304 24,955 6.33 84.7
2009 229 392,987 23,184 5.90 58.3
2010 299 393,176 22,898 5.82 76.0
2011 329 393,202 21,506 5.47 83.7
2012 378 394,681 20,669 5.24 95.8
2013 396,657 20,366 5.13
*Proportion of 19-y-olds relative to the number of children and adolescents. 
FIguRe 2. the point estimates of the prevalence rate of at-
tention deficit hyperactivity disorder (Adhd) in slovenia per 
100 000 children and adolescents (Ch&Ad). Calculation based 
on raw incidence data (dashed line), linear model for incidence 
rate (line with circles), exponential incidence model from 
1987 onwards (line with triangles), and exponential incidence 
model from 1980 onwards (solid line)
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referrals to specialist services (22). Third, in this period new 
drugs for ADHD became available (ie, nonstimulant atom-
oxetine and stimulant osmotic release oral delivery system 
methylphenidate), with pharmaceutical marketing in this 
field being increasingly active, which improved identifica-
tion and reduced negative attitudes toward pharmaco-
logical treatment (23). ADHD was underdiagnosed in Slo-
venia in comparison with other EU countries. In Germany, 
the 2008 prevalence rate according to the ICD-10 criteria 
was 1.0% (the estimate is based on a representative sam-
ple of parents of 2452 children and adolescents aged 7-17 
years), which is almost 2-fold higher than in Slovenia (11). 
In Spain, the 2011 prevalence rates of ADHD according to 
the ICD-10 in school-age children (6-12 years) were within 
the range of 1.2%, which is 2 times higher than in Slove-
nia (24). Similarly, in Great Britain the 2008 total prevalence 
of ADHD in children and adolescents aged from 13 to 17 
years was 7.4%, which is about 10 times higher than in Slo-
venia (25). A systematic review found no significant differ-
ences in the prevalence of ADHD between Europe and 
North America (10).
Underdiagnosis in Slovenia might be attributable to the 
fact that only few psychiatrists diagnose ADHD and pre-
scribe ADHD medicines. Also, there are no national guide-
lines for ADHD treatment and diagnosis, which would 
integrate the existing knowledge about ADHD into the 
Slovenian health care system (18,26). Parents and teachers 
also play a vital role and should be more extensively in-
cluded in the ADHD recognition scheme in Slovenia (27).
In many countries, the main barrier to providing treatment 
of psychiatric disorders is the limited treatment in primary 
care settings (28). In Slovenia, this is particularly the case 
because of the high workload of Slovenian family physi-
cians, meaning they are less likely to become involved in 
the treatment and prevention of mental health disorders, 
including ADHD (29,30). This leads to lower recognition 
and treatment of mental disorders and underprescription 
of psychiatric medicines (31). Slovenian psychiatry is pre-
dominantly hospital-based and thus poorly accessible. A 
program for the development of general community psy-
chiatric services in Slovenia is in its beginnings, but will 
have to face all kinds of obstacles before it can be thor-
oughly implemented and improve access, quality, and 
comprehensiveness of psychiatric care according to mod-
ern standards of psychiatric service delivery (30). Another 
reason for ADHD underdiagnosis in Slovenia is a low per-
centage of urban population in Slovenia, as higher world 
prevalence rates of ADHD were found in urban areas (32).
The incidence rates calculated in our four models show 
the models’ usefulness in the calculation of incidence data 
from the NIPH database as well as their wide applicability. 
The incidence rate of ADHD diagnosis obtained from the 
model 1 was deviated, but primarily because of inaccura-
cies in the database. In prevalence calculation, there were 
minimal differences among the models, which showed 
the usefulness and appropriateness of these models to es-
timate the future ADHD prevalence rate. These models can 
be used in planning resources to cope with the burden of 
ADHD (16).
Although data from western countries show a fast in-
crease in the number of ADHD patients in the last decade, 
in Slovenia this trend is observed with a big delay. How-
ever, this increase could be a result of improved diagnos-
tics and awareness, rather than an increase in real preva-
lence. Therefore, this issue needs to be investigated in a 
new study including regional data.
There are several advantages of using claims data for an 
epidemiological study of ADHD, for example using longi-
tudinal data from a large national population-based sam-
ple to calculate the annual incidence (32). However, this 
study has several limitations. First, we did not differentiate 
ADHD patients by disease subtypes. We defined ADHD as 
a chronic disorder in children and adolescents, which was 
not true in some cases, and it was also possible that some 
psychiatrists did not enter the correct diagnosis. Sex, and 
variables such as cultural background and socioeconom-
ic status were not available in the database. The database 
included only initial data upon diagnosis, with no follow-
up information. Moreover, the oscillation of the incidence 
data in the period from 2004 to 2012 was quite substan-
tial, so we used the mean value of data from this period. 
On the other hand, the data from 1997 to 2003 were more 
consistent allowing us to develop two regression models: 
linear and exponential. Finally, there was no available reg-
ister of ADHD patients in Slovenia, limiting the possibilities 
of cross-national data comparison. In order to determinate 
the “real” prevalence rate of ADHD in children and adoles-
cents we should have a registry of patients with ADHD, 
which has not yet been established in Slovenia. We also 
did not calculate regional differences due to the small size 
of the country, small number of patients with ADHD, and 
variability of access to ADHD specialists, which were avail-
able mainly in the two largest cities.
In this study the annual incidence and prevalence rate 
of ADHD diagnosis were evaluated using four differ-
PUBLIC HEALTH164 Croat Med J. 2015;56:159-65
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ent approaches. All four approaches gave were very simi-
lar results. The incidence and prevalence rate of children 
and adolescents with ADHD in Slovenia were increasing, 
but it was still 2 to 10 times lower than in some compa-
rable countries. According to the calculated prevalence 
of ADHD in Slovenia, the diagnosis rates in children and 
adolescents did not exceeded those expected according 
to the rates in Western countries (less than 1% in children 
and adolescents). All models showed similar results, which 
indicated that they were appropriate for calculating ADHD 
incidence and prevalence using national database data. 
The epidemiological models could be used to assist ADHD 
epidemiology calculation in other countries in the region. 
Finally, these data indicated an urgent need for further re-
search of health care utilization and quality of care in the 
field of ADHD in Slovenia.
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